TOPELIA AUSTRALIA

Topelia Australia has extensive expertise in commercializing the revolutionary triple therapy cure for peptic ulcers.

#Website #More

TOPELIA AUSTRALIA

Industry:
Fitness Health Care Wellness

Website Url:
http://www.topeliaaustralia.com

Status:
Active


Official Site Inspections

http://www.topeliaaustralia.com

  • Host name: a290d26420470737c.awsglobalaccelerator.com
  • IP address: 15.197.133.181
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Topelia Australia"

About Topelia | Topelia Aust Limited - Topelia Aust Pty Limited

About Topelia. Topelia Aust Limited (ABN 36 652 771 670) is a pioneering, public, unlisted biotechnology company committed to developing and commercialising its proprietary Antiviral …See details»

Investors | Topelia Aust Limited - Topelia Aust Pty Limited

Topelia Aust Pty Limited (ABN 36 652 771 670) (Topelia) is an unlisted biotechnology company focused on developing and commercialising its proprietary Antiviral Triple Therapy (ATT) …See details»

Topelia Overview | SignalHire Company Profile

Topelia Aust Limited (ABN 36 652 771 670) (Topelia) is a public, unlisted biotechnology company focused on developing and commercialising its proprietary Antiviral Triple Therapy (ATT) …See details»

Topelia Australia - Crunchbase Company Profile & Funding

Topelia Australia has extensive expertise in commercializing the revolutionary triple therapy cure for peptic ulcers.See details»

TOPELIA AUST LIMITED · Australia - OpenGovAU

TOPELIA AUST LIMITED (Entity# 652771670) is a business entity registered with Australian Securities and Investments Commission (ASIC). The business registration date is August 12, …See details»

Topelia Aust Ltd. - Drug pipelines, Patents, Clinical trials - Synapse

Aug 10, 2024 Explore Topelia Aust Ltd. with its drug pipeline, therapeutic area, technology platform, .See details»

Topelia Australia | VentureRadar

Website: https://www.topeliaaustralia.com/ Develops and commercialises a triple therapy cure for peptic ulcers, saving lives and reducing government medical costs.See details»

Vision and mission | Topelia Aust Limited - Topelia Aust Pty Limited

Topelia Aust Pty Limited (ABN 36 652 771 670) (Topelia) is an unlisted biotechnology company focused on developing and commercialising its proprietary Antiviral Triple Therapy (ATT) …See details»

Topelia Australia - AusBiotech

Topelia Australia . Topelia Aust Limited (ABN 36 652 771 670) (Topelia) is an unlisted biotechnology company focused on developing and commercialising its proprietary Antiviral Triple Therapy for coronavirus infection.See details»

Ziverdox - Drug Targets, Indications, Patents - Synapse

Originator Organization. Topelia Aust Ltd. Active Organization. Topelia Aust Ltd. Inactive Organization-Drug Highest Phase Phase 2. ... and more than 300 peer-reviewed papers …See details»

Topelia Australia - VentureRadar

"Topelia Australia was founded based on the wealth of experience in commercialising the ground-breaking triple therapy cure for peptic ulcers which has saved over 18 thousand lives in …See details»

Topelia Australia - PitchBook

Topelia Australia General Information Description. Developer of antiviral triple therapy intended to commercialize the triple therapy cure for peptic ulcers. The company's product offers antiviral …See details»

Topelia Australia - Techboard

Feb 21, 2022 Elevator Pitch: Topelia Australia, a biotech company established to commercialise a novel ATT treatment for Australians in quarantine, has launched an investment program …See details»

Overview of Topelia | Topelia Aust Limited - Topelia Aust Pty Limited

Overview of Topelia. Topelia Aust Limited is dedicated to developing and commercialising its proprietary Antiviral Triple Therapy (ATT), known as TPL101.Topelia's strategic approach …See details»

Topelia Australia - Crunchbase

Topelia Australia has extensive expertise in commercializing the revolutionary triple therapy cure for peptic ulcers.See details»

Topelia Australia launches US$25M Series A call for ... - ACN …

Oct 14, 2021 Professor Borody has more than 190 patents and applications, 3 FDA-approved drugs on the market, and more than 300 peer-reviewed papers published. Topelia Australia …See details»

Contact Us | Topelia Aust Limited

Topelia Aust Limited 1/229 Great N Rd, Five Dock, NSW 2046 ABN: 36 652 771 670 Email: [email protected]See details»

Our Philosophy | Topelia Aust Limited - Topelia Aust Pty Limited

Topelia Aust Pty Limited (ABN 36 652 771 670) (Topelia) is an unlisted biotechnology company focused on developing and commercialising its proprietary Antiviral Triple Therapy (ATT) …See details»

Topelia Australia launches US$25M Series A call for COVID-19 ATT ...

SYDNEY, Oct 14, 2021 - (ACN Newswire) - Topelia Australia, a biotech company established to commercialise a novel ATT treatment for Australians in quarantine, has launched an …See details»